For nearly two years, the Pradaxa lawyers at Saiontz & Kirk, P.A. have been reviewing and evaluating potential product liability lawsuits on behalf of individuals who suffered severe and uncontrollable bleeding problems caused by the relatively new anticoagulant. The number of new complaints filed nationwide continues… Read More
As individual Pradaxa lawsuits move forward in state and federal courts throughout the United States, alleging that side effects of the anticoagulant caused users to suffer uncontrollable bleeding problems, the first cases are being prepared for early trial dates that are expected to begin in August… Read More
Following an order (PDF) issued last week, the federal Pradaxa litigation will be consolidated as part of an MDL (multidistrict litigation), before Judge David R. Herndon in the U.S. District Court for the Southern District of Illinois. (more…) Read More
A petition has been filed in federal court calling for the consolidation of all lawsuits over bleeding problems with Pradaxa as part of a multidistrict litigation, or MDL, where the cases would be centralized before one judge for coordinated handling during pretrial proceedings. While many people… Read More
In recent months, there have been mounting concerns over the risks associated with side effects of Pradaxa, as health officials in the U.S., Canada and Europe were continuing to review reports involving serious bleeding problems and deaths among users of the anticoagulant. (more…) Read More
A recent medical case report published in the Annals of Pharmacotherapy highlights the risk of gastrointestinal bleeding from Pradaxa among elderly patients with kidney impairment, and underlines the impact of the manufacturer's failure to provide accurate information for medical providers about the need to appropriately select… Read More
Pradaxa (dabigatran) is a relatively new blood thinner, which was just introduced in October 2010 as a replacement for Coumadin (warfarin). However, in the short period of time the drug has been on the market, an alarming number of deaths and serious bleeds have occurred from… Read More
Although Boehringer Ingelheim, the maker of the new blood thinner Pradaxa, has attempted to suggest that the number of individuals who have experienced severe bleeding on their medication is in-line with other blood thinners, a recent report from a drug watchdog group highlights how serious and… Read More
A new study suggests that the blood thinner Pradaxa may be linked to an increased risk of heart attacks. (more…) Read More
The product liability lawyers at Saiontz & Kirk, P.A. previously reviewed potential Pradaxa lawsuits for individuals throughout the United States who have experienced severe internal bleeding or hemorrhaging, including gastrointestinal (GI) bleeds, brain hemorrhage, kidney bleeding, death or other bleeding problems. (more…) Read More
